Overall there is no consensus on the molecular process causing the forms of epilepsy associated with Nav1.2 since in vitro functional studies have demonstrated that LoF or GoF mutations can be involved in the epileptic phenotype. The gene discussed is SCN2A; the disease is epilepsy.